BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15605140)

  • 1. Less acid + less bleeding = better outcomes and more money!
    Enns R
    Can J Gastroenterol; 2004 Dec; 18(12):747-8; discussion 748. PubMed ID: 15605140
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of intravenous proton pump inhibitors in high-risk bleeders.
    van Zanten SV
    Can J Gastroenterol; 2004 Dec; 18(12):749-50. PubMed ID: 15605141
    [No Abstract]   [Full Text] [Related]  

  • 3. Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage.
    Martin RA
    Conn Med; 2004 Aug; 68(7):435-8. PubMed ID: 15384242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An audit of argon plasma coagulation, epinephrine injection, and proton-pump infusion therapy in the management of bleeding peptic ulcer disease.
    Yap LM; Hagan S; Craig A; Hebbard GG; Young GP; Bampton PA
    Endoscopy; 2004 Apr; 36(4):371-2; author reply 372-3. PubMed ID: 15057696
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study.
    Andrews CN; Levy A; Fishman M; Hahn M; Atkinson K; Kwan P; Enns R
    Can J Gastroenterol; 2005 Nov; 19(11):667-71. PubMed ID: 16292361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching between intravenous and oral pantoprazole.
    Pisegna JR
    J Clin Gastroenterol; 2001 Jan; 32(1):27-32. PubMed ID: 11154164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
    Metz DC
    Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost-minimization study on the prescription of intravenous proton pump inhibitors: pantoprazole versus omeprazole].
    García González F; Soler Company E; Hedo Aparicio G
    Farm Hosp; 2003; 27(6):339-45. PubMed ID: 14974879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
    Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate use of intravenous pantoprazole: extent of the problem and successful solutions.
    Kaplan GG; Bates D; McDonald D; Panaccione R; Romagnuolo J
    Clin Gastroenterol Hepatol; 2005 Dec; 3(12):1207-14. PubMed ID: 16361046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The Netherlands.
    van Hout BA; Klok RM; Brouwers JR; Postma MJ
    Clin Ther; 2003 Feb; 25(2):635-46. PubMed ID: 12749518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent anaphylaxis associated with pantoprazole.
    Gratacós L; Soy D; Lluís M; López B; Nicolás JM; Codina C; Nogué S; Ribas J
    Am J Health Syst Pharm; 2005 Jul; 62(13):1388-9. PubMed ID: 15972383
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis.
    Sennaroglu E; Karakan S; Kayatas M; Akdur S; Genc H; Karakan T; Ucler R; Ozisler C; Urun Y
    Dig Dis Sci; 2006 Jan; 51(1):121-2. PubMed ID: 16416223
    [No Abstract]   [Full Text] [Related]  

  • 14. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial.
    Zargar SA; Javid G; Khan BA; Yattoo GN; Shah AH; Gulzar GM; Sodhi JS; Mujeeb SA; Khan MA; Shah NA; Shafi HM
    J Gastroenterol Hepatol; 2006 Apr; 21(4):716-21. PubMed ID: 16677158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [All proton pump inhibitors are equally efficacious in standard dosages].
    Hellström PM; Vitols S
    Lakartidningen; 2003 Jun; 100(25):2212-6. PubMed ID: 12872509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of acute peptic ulcers: how ethnicity, different proton pump inhibitors and mechanism of delivery alter the equation.
    Tan VP; Wong BC
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1157-8. PubMed ID: 19682187
    [No Abstract]   [Full Text] [Related]  

  • 17. Pantoprazole, Prout and the proton pump.
    Playford RJ; Podas T; Modlin I
    Hosp Med; 1999 Jul; 60(7):500-4. PubMed ID: 10605542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of intravenously administered pantoprazole in the treatment of gastrinoma].
    Modlin IM
    Recenti Prog Med; 2001; 92(7-8):456-61. PubMed ID: 11475787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antisecretor treatment of digestive hemorrhage associated to peptic ulcer: an approximation to the available evidence].
    Bustamante Baléna M; Ponce García J
    Rev Clin Esp; 2004 Mar; 204(3):161-8. PubMed ID: 15025985
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage?
    Guda NM; Noonan M; Kreiner MJ; Partington S; Vakil N
    Am J Gastroenterol; 2004 Jul; 99(7):1233-7. PubMed ID: 15233659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.